Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Shea, MD
UNC Lineberger Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Veterans Affairs Medical Center - San Diego
San Diego, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- St. Francis Hospital
Wilmington, Delaware, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Union Hospital Cancer Center at Union Hospital
Elkton MD, Maryland, United States
- Umass Memorial Cancer Center - University Campus
Worcester, Massachusetts, United States
- Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
Voorhees Township, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Elmhurst Hospital Center
Elmhurst, New York, United States
- Queens Cancer Center of Queens Hospital
Jamaica, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
Columbus, Ohio, United States
- Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, United States
- Massey Cancer Center at Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2001
- Primary completion
- 31 Jan 2007
- Completion
- 31 Oct 2011
- Last update posted
- 18 Jul 2016
- Registered enrollment
- 47
- Registry id
- NCT00006252
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.